28513K.KO SK Chemicals Co Ltd Pref
- Market cap
- KRW 405B
- P/E
- -
- P/B
- 0.18x
- ROE
- -0.3%
- Dividend yield
- 5.56%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 28513K.KO undervalued?
Graham numberThe Graham number of SK Chemicals Co Ltd Pref cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SK Chemicals Co Ltd Pref fundamental analysis
No fundamental analysis for SK Chemicals Co Ltd Pref yet.
SK Chemicals Co Ltd Pref stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SK Chemicals Co Ltd Pref
SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea, China, Japan, Asia, the United States, Europe, and internationally. The company offers copolyester, engineering plastic, petro chemical, specialty chemical, coating and adhesive, biomaterial, and performance chemical for covid-19 personal protective equipment, industrial materials, sustainable packaging solution, packaging, cosmetic, automotive, consumer goods and sports, and ele…
Full company profileSK Chemicals Co Ltd Pref financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SK Chemicals Co Ltd Pref annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 87.8B | 1.37T | 1.43T | 1.21T | 2.09T | 1.83T | 1.75T | 1.74T | 2.37T | 2.80T |
| Gross Profit | - | 12.7B | 272B | 326B | 350B | 881B | 615B | 473B | 396B | 499B | 602B |
| Operating Income | - | -9.18B | 45.7B | 80.3B | 106B | 555B | 230B | 83.7B | -44.8B | 280M | 27.5B |
| EBITDA | - | -2.87B | 125B | 159B | 142B | 642B | 344B | 197B | 150B | 256B | 281B |
| Net Income | - | -8.54B | 6.03B | 10.6B | 254B | 168B | 191B | 39.9B | 8.84B | 44.6B | -6.63B |
| EPS | - | -737 | 521 | 903 | 21,684 | 9,549 | 11,120 | 2,315 | 513 | 2,592 | -384 |
| Balance Sheet | |||||||||||
| Total Assets | - | 1.91T | 1.95T | 2.13T | 2.12T | 3.96T | 3.95T | 4.16T | 5.37T | 6.09T | 6.51T |
| Total Liabilities | - | 1.18T | 1.23T | 1.41T | 1.16T | 1.39T | 1.24T | 1.48T | 2.33T | 2.95T | 3.07T |
| Shareholders' Equity | - | 697B | 692B | 716B | 953B | 2.05T | 2.15T | 2.12T | 2.20T | 2.26T | 2.47T |
| Cash & Short-term Investments | - | 155B | 45.3B | 184B | 86.8B | 256B | 400B | 396B | 542B | 568B | 675B |
| Cash Flow | |||||||||||
| Operating Cash Flow | -128B | -128B | 67.4B | 122B | 247B | 509B | -187B | 146B | -89.3B | 236B | 47.8B |
| Capital Expenditure | 0.00 | 102B | 81.9B | 127B | 94.8B | 140B | 290B | 400B | 440B | 466B | 402B |
| Free Cash Flow | - | -19.5B | -17.1B | -7.70B | 150B | 362B | -489B | -254B | -530B | -230B | -355B |
| Ratios | |||||||||||
| ROE | - | -1.2% | 0.9% | 1.5% | 26.7% | 8.2% | 8.9% | 1.9% | 0.4% | 2.0% | -0.3% |
| ROA | - | -0.4% | 0.3% | 0.5% | 12.0% | 4.3% | 4.8% | 1.0% | 0.2% | 0.7% | -0.1% |
| Net Profit Margin | - | -9.7% | 0.4% | 0.7% | 20.9% | 8.0% | 10.5% | 2.3% | 0.5% | 1.9% | -0.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SK Chemicals Co Ltd Pref dividends
- Dividend yield
- 5.56%
- Forward dividend
- 1,200.00 KRW
- Payout ratio
- 50.5%
- Ex-dividend date
- Aug 6, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 22.5B | 1,308 | 50.5% |
| 2024 | KRW 17.6B | 1,024 | 199.6% |
| 2023 | KRW 29.9B | 1,735 | 75.0% |
| 2022 | KRW 67.2B | 3,909 | 35.2% |
| 2021 | KRW 26.1B | 1,485 | 15.6% |
| 2020 | KRW 6.01B | 512 | 2.4% |
| 2019 | KRW 5.28B | 450 | 49.8% |
| 2018 | KRW 5.28B | 457 | 87.6% |
| 2017 | KRW 5.28B | 456 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns SK Chemicals Co Ltd Pref
- Insiders 10.48%
- Institutions 5.22%
- Public & others 84.30%
- Shares outstanding 2.11M
- Free float 12.0M
SK Chemicals Co Ltd Pref company profile
- Company name
- SK Chemicals Co Ltd Pref
- Ticker
- 28513K.KO
- ISIN
- KR728513K010
- Exchange
- Korea Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,406
- Fiscal year end
- December
- Address
- 310, Pangyo-ro, Seongnam-si, South Korea, 13494
- Phone
- 82 2 2008 2008
- Website
- skchemicals.com
About SK Chemicals Co Ltd Pref
SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea, China, Japan, Asia, the United States, Europe, and internationally. The company offers copolyester, engineering plastic, petro chemical, specialty chemical, coating and adhesive, biomaterial, and performance chemical for covid-19 personal protective equipment, industrial materials, sustainable packaging solution, packaging, cosmetic, automotive, consumer goods and sports, and electronics and home appliance applications. It sells its products under the SKYGREEN, SKYPEL, SKYBON, ECOZEN, SKYTRA, ECOTRION, CLARO, SKYDMT, CnR, ECOTRIA, SKYCHDM, E.Chemical, SKYPET, SKYDMCD, SKYPURA, and SKYCHDA brands. The company provides ETC drugs, including musculoskeletal system, anti-inflammatory agents/analgenics, digestive system, central nervous system, respiratory system, urinary system, kidney/rheumatism, circulatory system/metabolic disease, antimicrobial/antiviral agents, and others; OTC drugs, such as common cold/antihistamine, drugs to improve blood flow, vitamins/minerals, dermatologicals, and other products. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.
SK Chemicals Co Ltd Pref management
2- Mr. Jae-Hyeon AhnCEO, President & Director
- Mr. Cheol KimCEO & Inside Director · born 1961